跳到主要內容

臺灣博碩士論文加值系統

(216.73.216.152) 您好!臺灣時間:2025/11/06 11:31
字體大小: 字級放大   字級縮小   預設字形  
回查詢結果 :::

詳目顯示

我願授權國圖
: 
twitterline
研究生:林美淑
研究生(外文):Lin, Mei-Shu
論文名稱:制酸劑之效力評估及其對腸溶錠崩散度之影響:體外試驗
論文名稱(外文):In vitro Study on The Efficacies of Antacids and Their Effect on The Disintegration of Enteric Coated Tablets
指導教授:余秀瑛余秀瑛引用關係
指導教授(外文):Yu, Hsiu-Ying
學位類別:碩士
校院名稱:國立臺灣大學
系所名稱:藥學研究所
學門:醫藥衛生學門
學類:藥學學類
論文種類:學術論文
論文出版年:1996
畢業學年度:84
語文別:中文
論文頁數:98
中文關鍵詞:制酸劑腸溶錠酸中和效力崩散度
外文關鍵詞:AntacidsEnteric coated tabletsAcid neutralizing capacityDisintegration
相關次數:
  • 被引用被引用:2
  • 點閱點閱:871
  • 評分評分:
  • 下載下載:0
  • 收藏至我的研究室書目清單書目收藏:2
「制酸劑是否可與任何腸溶錠同時服用」尚無明確之實驗根據,以致指導
服藥時無所適從。本實驗之目的在研究制酸劑對腸溶錠崩散度之影響。收
集台大醫院常用之制酸劑(Fanta suspension,Obira gel,CaCO3,MgO
, Nacid,NaHCO3,Ulcerin-P )及腸溶錠(Bradilan,Convulex,Danzen
, Dulcolax,Ecotrin,Mesin, Salazopyrin,Voren)進行實驗。首先根
據 USP XXIII 之規格鑑定制酸劑之品質、中和胃酸能力,再模擬生理狀
態之胃酸中和經時變化測定制酸劑緩衝胃酸之效果,結果顯示七種制酸劑
之效果相差極大。其中Obira gel依照 USP 規格不能算是制酸劑。在模擬
胃生理狀態時可使胃酸pH值上升至3.5以上之制酸劑(Fanta 20ml,Fanta
10ml, CaCO3 2粒,Nacid 2粒,Nacid 1粒,NaHCO3 2粒)則繼續檢定在人
工胃液中是否會影響腸溶錠之崩散。先依 USP XXIII 腸溶錠崩散度試驗
法鑑定上述腸溶錠皆符合規定。再依序以下列三種方法試驗:I、將人工
胃液先以制酸劑處理再依 USP XXIII 法做崩散度試驗。II、在攪拌中之
人工胃液與制酸劑之混合液中做崩散度試驗。III、模擬生理狀態胃液分
泌速率(1.8ml/ min)測試制酸劑中和胃酸之經時變化對腸溶錠崩散之影
響.制酸劑之添加量則依臨床劑量/胃液生理體積之比例。I法不崩散的腸
溶錠才做II法. 因為II法可充分攪拌制酸劑和人工胃液的混和液,達到之
pH值比I法高。在I或II法會崩散的腸溶錠才做第III法。結果得知
Dulcolax和Ecotrin之崩散 皆不受任何制酸劑之影響。而Voren最不耐制
酸劑,在I、 II法中受任何制酸劑之影響而崩散。其餘五種腸溶錠(
Bradilan,Convulex, Danzen, Mesin, Salazopyrin)則因制酸劑之種類或
劑量而有不同表現。 Fanta 20ml和NaHCO3 2粒之影響最大且相似,可使
這五種腸溶錠在I法中即崩散,甚至使Convulex, Mesin在III法中亦崩散
;Nacid之影響最小,且1粒與2粒之影響相似,皆不影響這五種腸溶錠在I
、II、III法中之崩散度。Fanta 10ml 和CaCO3 2粒之影響相似,在I、
III法中不影響這五種腸溶錠之崩散度,但在II法中會使多種腸溶錠崩散
。本實驗結果中,何種測試法與在體內之藥物交互作用狀況相關性最好,
則有待進一步研究.
The purpose of this study is to investigate the influence of
antacids on the disintegration of enteric coated drugs. The
antacids and enteric coated tablets are collected from National
Taiwan University Hospital. The quality of the antacids, in
terms of preliminary antacid test (PAT) and neutralizing
capacity (ANC) , as well as the quality of the enteric coated
tablets, in terms of disintegration time were tested according
to USP XXIII. In addition, the buffering capacity of antacids
was tested in simulated physiological gastric secretion.
According to USP XXIII criteria,Obira gel,showing a pH below
3.5 in preliminary antacid test (PAT), should not be labeled as
an antacid, and was excluded from further experiment. The
influence of the antacids on the disintegration of enteric
coated tablets was tested by the following methods : I、tested
according to USP XXIII with modification by adding the antacid
to simulated gastric juice in the proportion of clinical dose /
physiological gastric volume; II、tested in the mixture of
antacids and simulated gastric juice with constant stirring on
a stirer; III、tested in a mixture of simulated gastric juice
containing a dose of antacid, with constant input (1.8 ml/min)
of fresh simulated gastric juice and drainage of an equal
volume of the reaction mixture from the container. The results
demonstrated that the enteric coating of Dulcolax and Ecotrin
were tolerable to any of the antacids in the three methods,
while that of Voren was the most labile to any of the antacids
in method I and II. NaHCO3 and Fanta 20ml showed the most
strong effects,causing disintegration of the five enteric
coated tablets in method I. On the contrary, Nacid, either 1 or
2 tablets, did not influence the disintegration of the five
enteric coated tablets in the three methods. CaCO3 and Fanta
10ml were moderate,causing disintegration of most tablets only
in method
QRCODE
 
 
 
 
 
                                                                                                                                                                                                                                                                                                                                                                                                               
第一頁 上一頁 下一頁 最後一頁 top